NCT03298087 2025-08-01Systemic and Tumor-Directed Therapy for Oligometastatic Prostate CancerVA Office of Research and DevelopmentPhase 2 Completed28 enrolled 10 charts
NCT05422911 2022-06-21Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.James J. Peters Veterans Affairs Medical CenterPhase 2 Not yet recruiting200 enrolled